SAB BIOTHERAPEUTICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
SAB BIOTHERAPEUTICS, INC. (SABS) had Common Stock, Capital Shares Reserved for Future Issuance of 12.88 million shares as of 2023-06-30, per its 10-Q filed 2023-08-21.
Discontinued › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2023-08-21
- 2023-06-30: Common Stock, Capital Shares Reserved for Future Issuance 12.88M shares.
- 2023-03-31: Common Stock, Capital Shares Reserved for Future Issuance 12.88M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2023-06-30 | 12.88M shares 10-Q · filed 2023-08-21 |
| 2023-03-31 | 12.88M shares 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |